Antiviral resistance mutations potentiate HBV surface antigen-induced transcription of hfgl2 prothrombinase gene

By Li Weina   Han Meifang   Li Yong   Chen Dan   Luo Xiaoping   Ning Qin  

Biochemistry (Moscow), Vol. 76, Iss. 9, 2011-09 ,pp. : 1043-1050

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Evaluation of Anti-Hepatitis B Virus (HBV) Drugs Using the HBV Transgenic Mouse: Application of the Semiquantitative Polymerase Chain Reaction (PCR) for Serum HBV DNA to Monitor the Drug Efficacy

By Kajino K.   Kamiya N.   Yuasa S.   Takahara T.   Sakurai J.   Yamamura K.I.   Hino O.  

Biochemical and Biophysical Research Communications, Vol. 241, Iss. 1, 1997-12 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Stabilization of Poliovirus by Capsid-binding Antiviral Drugs is due to Entropic Effects

By Tsang S.K.   Danthi P.   Chow M.   Hogle J.M.  

Journal of Molecular Biology, Vol. 296, Iss. 2, 2000-02 ,pp. : 335-340

Academic Press

Access to resources Recommend Favorite

Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response

By Miroux Céline   Vausselin Thibaut   Delhem Nadira  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1563-1572

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for malignant liver disease

By Mohr Leonhard   Geissler Michael   Blum Hubert E  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 163-175

Informa Healthcare

Access to resources Recommend Favorite